Skip to content
drillr.ai
Sign up

MAZE

Maze Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$26.21
+1.31%
Ask drillr
0
Insider buys (3m)
20
Insider sells (3m)
-$5.5M
Net value (3m)
+8.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 3, 2026Courtney Phillips · officer: GC and Corp. SecretaryM-Exempt11,000$0.00
Sep 3, 2026Bernstein Harold · officer: President, R&D & CMOM-Exempt20,000$0.00
Sep 3, 2026Bernstein Harold · officer: President, R&D & CMOSale16,141$26
Sep 3, 2026Bernstein Harold · officer: President, R&D & CMOM-Exempt16,141$10
Sep 3, 2026Coloma Jason V · director, officer: Chief Executive OfficerM-Exempt50,000$0.00
Sep 3, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale31,908$26
Sep 3, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale2,593$26
Sep 3, 2026Dandekar Atul · officer: CSBOM-Exempt12,500$0.00
Aug 31, 2026Dandekar Atul · officer: CSBOSale7,500$28
Aug 31, 2026Dandekar Atul · officer: CSBOM-Exempt7,500$10
Aug 17, 2026Johnson Paula A · directorA-Award36,000$28
Aug 17, 2026Kornowski Sophie · directorA-Award36,000$28
Aug 14, 2026Bernstein Harold · officer: President, R&D & CMOSale16,142$28
Aug 14, 2026Bernstein Harold · officer: President, R&D & CMOM-Exempt16,142$10
Aug 5, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale154$27
Aug 5, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale1,604$27
Aug 5, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale30,304$27
Aug 5, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale2,439$27
Jul 31, 2026Dandekar Atul · officer: CSBOSale7,100$27
Jul 31, 2026Dandekar Atul · officer: CSBOSale400$28
Jul 31, 2026Dandekar Atul · officer: CSBOM-Exempt7,500$10
Jul 2, 2026Bernstein Harold · officer: President, R&D & CMOSale13,409$30
Jul 2, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale1,597$30
Jul 2, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale30,311$30
Jul 2, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale2,593$30
Jul 2, 2026Bernstein Harold · officer: President, R&D & CMOSale1,200$30
Jul 2, 2026Bernstein Harold · officer: President, R&D & CMOM-Exempt14,609$10
Jul 1, 2026Dandekar Atul · officer: CSBOSale7,500$28
Jul 1, 2026Dandekar Atul · officer: CSBOM-Exempt7,500$10
Jun 24, 2026Coloma Jason V · director, officer: Chief Executive OfficerSale1,953$26
Institutional positioning

13F filings over the trailing two quarters

New 53Increased 60Reduced 37Sold out 165
FilerActionSharesFiled
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.Unchanged4,567,274May 15, 2026
TRV GP IV, LLCUnchanged4,473,958May 7, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged4,120,053May 15, 2026
DEEP TRACK CAPITAL, LPReduced3,477,562May 15, 2026
JANUS HENDERSON GROUP PLCReduced2,858,876May 18, 2026
PARADIGM BIOCAPITAL ADVISORS LPNew Position2,744,399May 15, 2026
BLACKROCK, INC.Increased2,570,425May 13, 2026
AH CAPITAL MANAGEMENT, L.L.C.Unchanged1,702,225May 15, 2026
VR ADVISER, LLCIncreased1,602,034May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,435,656May 15, 2026
ALPHABET INC.Unchanged1,388,583May 8, 2026
LOGOS GLOBAL MANAGEMENT LPIncreased1,235,000May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.New Position1,178,000May 15, 2026
GENERAL CATALYST GROUP MANAGEMENT, LLCUnchanged1,035,910May 15, 2026
TRV GP V, LLCUnchanged950,800May 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026